Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.51
-6.59%
After-hours: Aug 22, 2025, 07:57 PM EDT

Aspire Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
3.63K 11.17K 38.00
Short-Term Investments
n/a n/a n/a
Long-Term Investments
6.67M 19.9M 299M
Other Long-Term Assets
-6.67M -24.87M -303.9M
Receivables
36.5K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
-36.5K n/a n/a
Total Current Assets
147.99K 46.17K 22.54K
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a 4.97M 4.9M
Total Long-Term Assets
n/a n/a n/a
Total Assets
147.99K 46.17K 22.54K
Account Payables
310.22K 172.77K 122.73K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
1.27M 360.64K 27.97K
Other Current Liabilities
111.03K 626.00 626.00
Total Current Liabilities
1.69M 534.03K 151.33K
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a
Total Liabilities
1.69M 534.03K 151.33K
Total Debt
1.27M 360.64K 27.97K
Common Stock
22K 22K 221.5K
Retained Earnings
-2.78M -1.47M -1.11M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-1.54M -487.86K -128.79K
Total Investments
6.67M 19.9M 299M